We came across a bullish thesis on Intuitive Surgical, Inc. on Uncle Stock Notes’s Substack. In this article, we will ...

Intuitive Surgical (NasdaqGS:ISRG) received FDA clearance for its da Vinci 5 system to be used in certain cardiac procedures.

Intuitive Surgical's 2025 earnings were strong, and the future remains bright, with valuation as the only big concern for investors.

Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the ...

Intuitive Surgical received FDA clearance for its da Vinci 5 system in selected cardiac procedures, including mitral valve repair and cardiac revascularization. The approval enables minimally invasive ...

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

Medtronic's Hugo robotic surgery system has been approved in the U.S. for urologic procedures. The company is also a leader ...

Investing.com -- TD Cowen initiated coverage of Intuitive Surgical with a Buy rating and a $660 price target, saying the launch of the da Vinci 5 system is driving a long-tailed product cycle that can ...

The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping up its presence in ambulatory surgery centers.

Zacks Equity Research shares Intuitive Surgical, Inc. ISRG, as the Bull of the Day and KB Home KBH as the Bear of the D ...

Intuitive Surgical (NASDAQ: ISRG) reports in-line Q4 results, sets measured guidance for 2026, with an 18% revenue growth and ...

SUNNYVALE, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the ...